News

James Hobson Takes the Helm at Ubiquity Retirement + Savings

James Hobson Takes the Helm at Ubiquity Retirement + Savings

Ubiquity Retirement + Savings Welcomes New CEO James Hobson

Proven financial services leader, James Hobson, joins Ubiquity to enhance its small business retirement platform by emphasizing partnerships.

In an exciting development, Ubiquity Retirement + Savings announced the appointment of James Hobson as its new Chief Executive Officer. This strategic decision comes at a time when the company is ready to advance its mission of providing exceptional retirement solutions to small and mid-sized businesses. Under Hobson’s guidance, Ubiquity aims to fortify its position as a leader in affordable and compliant retirement plans.

The demand for quality retirement plans is on the rise, influenced by new regulations and the heightened focus on employee retention and financial wellness. Ubiquity is dedicated to facilitating access for entrepreneurs and small business owners to offer robust retirement benefits, ensuring a hassle-free experience without unexpected costs.

James Hobson brings extensive experience in leading technology-driven financial services firms, having previously served as CEO of Attune Insurance. Throughout his career, he has demonstrated a unique ability to grow companies effectively while maintaining a client-centric focus. At Attune, he played a pivotal role in expanding the product line and enhancing relationships with partners, showcasing his capability in scaling businesses responsibly in regulated environments.

"Ubiquity has established a solid trust within the small business community. As we enter this new growth phase, having the right leadership is crucial," declared John Pasquesi, Founder of Otter Capital and board member at Ubiquity. He emphasized that Hobson's expertise would ensure sustainable growth while maintaining the company’s trusted reputation. This leadership transition promises to reinforce stability and strengthen Ubiquity's ability to expand its positive impact in the market.

Hobson expressed his enthusiasm about joining Ubiquity, stating, "Since its inception, Ubiquity has been a trailblazer in providing small businesses with tech-enabled, cost-effective retirement plans. I look forward to collaborating with the Ubiquity team and our partners to further enhance the 401(k) plan experience for small businesses across the country." This renewed focus aims to enhance accessibility to suitable retirement options for small businesses and their employees.

James Hobson steps into this role following the retirement of Chad Parks, who dedicated 25 years of leadership to the company. Hobson will collaborate closely with the leadership team to steer the organization toward its future objectives, underlining the company’s commitment to long-term relationships with clients and partners.

For more information on Ubiquity’s retirement solutions, including customizable 401(k) options tailored to the needs of small business owners, visit www.myubiquity.com.

About Ubiquity Retirement + Savings
Since 1999, Ubiquity has continuously aimed to provide small business owners with effective retirement plans tailored to their requirements, propelling them towards financial success. By combining innovative technology with a transparent flat-fee pricing model, flexibility, and outstanding customer support, Ubiquity has positively impacted numerous businesses and individuals. To learn more about its offerings, visit www.myubiquity.com.

Media Contact Information:
Interdependence for Ubiquity Retirement + Savings
Russ Pagano | (973) 303-3237 | [email protected]

Frequently Asked Questions

What is the significance of James Hobson's appointment?

James Hobson's appointment signals Ubiquity's commitment to growth and strengthening its position in the small business retirement sector.

What does Ubiquity offer small businesses?

Ubiquity provides affordable and compliant retirement plans, tailored specifically for small and mid-sized businesses, focusing on ease of use and transparency.

How has Ubiquity transformed retirement plans?

Ubiquity has transformed retirement planning by leveraging technology and offering flat-fee pricing, making it easier for small businesses to provide retirement benefits.

What experience does James Hobson bring to Ubiquity?

James Hobson has extensive experience leading financial services firms and has a successful track record in scaling businesses while maintaining a customer-centric approach.

How can small businesses learn more about Ubiquity's offerings?

Small businesses can learn about Ubiquity's retirement solutions and 401(k) options by visiting their official website.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Lilly's Sofe-M Shakes Up Ovarian Cancer Treatment

Updated Category News Views 295

Ovarian Cancer Treatment Sees a New Challenger Alright, folks, Eli Lilly (NYSE:LLY) is stepping up with their latest findings in ovarian cancer treatment, and it's got plenty of people in a buzz. They've dropped new data for their investigational drug, Sofetabart mipitecan, or 'Sofe-M' for short, which targets this unrelenting disease with a punch that’s hard to ignore....

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 143

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 132

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 143

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 214

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 160

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 185

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 70

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 270

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 69

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading

Top 5 Most Recently Viewed Articles

WTW Welcomes Dale Porfilio as Director for Business Development

Updated Category News Views 138

WTW Appoints New Leader for Business Development In a significant move to enhance its operations, WTW (NASDAQ: WTW) has announced the appointment of Dale Porfilio as Senior Director and Head of Personal and Commercial Lines Business Development within its Insurance Consulting & Technology (ICT) segment. A Seasoned Professional Joins WTW Porfilio brings a wealth of...

Continue Reading
Jorgen Vig Knudstorp's Bold Stock Purchase at Starbucks

Updated Category News Views 74

Jorgen Vig Knudstorp Invests in Starbucks, Showing Strong Confidence Recently, Jorgen Vig Knudstorp, a director at Starbucks Corp (NASDAQ:SBUX), made a significant move by buying shares of the company. This act signals a firm vote of confidence in the future of the beloved coffee chain. When insiders make such investments, it often grabs the attention of other investors...

Continue Reading
Understanding Inventiva's Latest Half-Year Report and Future Plans

Updated Category News Views 65

Inventiva Files its 2024 Half-Year Report Inventiva, a prominent clinical-stage biopharmaceutical company, is making significant strides in the healthcare sector. Focused on developing oral therapies for metabolic dysfunction-associated steatohepatitis, commonly known as MASH/NASH, the company recently announced its filing of the 2024 Half-Year Report for the period...

Continue Reading
Analyzing Organon's Upcoming Earnings Announcement and Insights

Updated Category News Views 177

Anticipation Surrounding Organon's Earnings Report Organon (OGN) is on the verge of revealing its quarterly earnings report, a moment eagerly awaited by investors. As preparations finalize for this significant announcement, understanding the forecasted outcomes can guide investor decisions moving forward. Expected Earnings Figures Forecast estimates suggest that Organon...

Continue Reading
Miami Real Estate Trends: A Surge in Older Condo Sales

Updated Category News Views 180

Understanding the Miami-Dade Real Estate Market Miami-Dade County's real estate landscape is shifting, with older condominiums experiencing quicker sales than their newer counterparts. This trend indicates a solid demand for older condos, highlighting their appeal in a market where affordable housing options continue to thrive. Statistical data reveal that older...

Continue Reading